Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
Elham NasriDianne E TorrenceTerrie VasilopoulosJacquelyn A KnapikJoanne P LagmayJohn D ReithCharles Parker Gibbs
Published in: Cancer journal (Sudbury, Mass.) (2024)
The results of this study, once proven to be reproducible by a larger number of patients, will be valuable in the initial assessment and risk stratification of the patients for treatment and possibly the clinical trials.